SS
NVCR icon

Steve Schonfeld’s NovoCure NVCR Stock Holding History

Steve Schonfeld’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-144,728
Closed -$1.87M – 2521
2025
Q4 		$1.87M Buy
144,728
+113,599
+365% +$1.46M 0.01% 899
2025
Q3 		$402K Buy
+31,129
New +$416K ﹤0.01% 1746
2025
Q1 		– Sell
-105,280
Closed -$3.14M – 2414
2024
Q4 		$3.14M Buy
+105,280
New +$2.23M 0.02% 660
2024
Q3 		– Sell
-101,140
Closed -$1.73M – 2296
2024
Q2 		$1.73M Sell
101,140
-262,637
-72% -$4.62M 0.01% 968
2024
Q1 		$5.69M Buy
363,777
+287,014
+374% +$4.22M 0.04% 596
2023
Q4 		$1.15M Buy
76,763
+28,113
+58% +$376K 0.01% 985
2023
Q3 		$786K Buy
+48,650
New +$1.4M 0.01% 1093
2023
Q1 		– Sell
-342
Closed -$25.1K – 2470
2022
Q4 		$25.1K Buy
+342
New +$25.7K ﹤0.01% 2306
2022
Q2 		– Sell
-11,300
Closed -$936K – 2859
2022
Q1 		$936K Buy
+11,300
New +$832K 0.01% 1029
2021
Q4 		– Sell
-1,812
Closed -$211K – 2410
2021
Q3 		$211K Buy
+1,812
New +$274K ﹤0.01% 1737
2020
Q4 		– Sell
-5,296
Closed -$589K – 1777
2020
Q3 		$589K Buy
+5,296
New +$423K 0.01% 863
2020
Q2 		– Sell
-14,674
Closed -$988K – 1459
2020
Q1 		$988K Buy
+14,674
New +$1.16M 0.06% 374
2019
Q4 		– Sell
-15,097
Closed -$1.13M – 1424
2019
Q3 		$1.13M Buy
+15,097
New +$1.21M 0.03% 445

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Steve Schonfeld's NVCR Position: Q1 2026 in Review

Steve Schonfeld sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 144,728 shares — an estimated $1.87M sold.

Steve Schonfeld first reported a position in NVCR in Q3 2019 and held it in 13 quarters. The position peaked at $5.69M in Q1 2024. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Steve Schonfeld reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 144,728 NovoCure shares in Q1 2026, an estimated $1.87M.
  • Steve Schonfeld first reported a position in NovoCure in Q3 2019 and held it in 13 quarters.
  • Steve Schonfeld's NovoCure position peaked at $5.69M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.